메뉴 건너뛰기




Volumn 96, Issue 8, 2012, Pages 1153-1154

Resistance, not tachyphylaxis or tolerance

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; VASCULOTROPIN INHIBITOR;

EID: 84864849235     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-301823     Document Type: Letter
Times cited : (9)

References (7)
  • 1
    • 84455180610 scopus 로고    scopus 로고
    • Loss of reactivity in intravitreal anti-VEGF therapy: Tachyphylaxis or tolerance?
    • Binder S. Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance? Br J Ophthalmol 2012;96:1-2.
    • (2012) Br J Ophthalmol , vol.96 , pp. 1-2
    • Binder, S.1
  • 2
    • 84455204035 scopus 로고    scopus 로고
    • Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab
    • Eghoj MS, Sorensen TL. Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab. Br J Ophthalmol 2012;96:21-3.
    • (2012) Br J Ophthalmol , vol.96 , pp. 21-23
    • Eghoj, M.S.1    Sorensen, T.L.2
  • 3
    • 84455206370 scopus 로고    scopus 로고
    • Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation
    • Gasperini JL, Fawzi AA, Khondkaryan A, et al. Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation. Br J Ophthalmol 2012;96:14-20.
    • (2012) Br J Ophthalmol , vol.96 , pp. 14-20
    • Gasperini, J.L.1    Fawzi, A.A.2    Khondkaryan, A.3
  • 4
    • 64049108890 scopus 로고    scopus 로고
    • Resistance to EGF-R (erB-1) and VEGF-R modulating agents
    • Dempke WC, Heinemann V. Resistance to EGF-R (erB-1) and VEGF-R modulating agents. Eur J Cancer 2009;45:1117-28.
    • (2009) Eur J Cancer , vol.45 , pp. 1117-1128
    • Dempke, W.C.1    Heinemann, V.2
  • 5
    • 84863305116 scopus 로고    scopus 로고
    • Mechanisms of resistance to vascular endothelial growth factor blockade
    • Abdullah SE, Perez-Soler R. Mechanisms of resistance to vascular endothelial growth factor blockade. Cancer 2012;118:3455-3467.
    • (2012) Cancer , vol.118 , pp. 3455-3467
    • Abdullah, S.E.1    Perez-Soler, R.2
  • 6
    • 79957894276 scopus 로고    scopus 로고
    • Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
    • Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 2011;10:417-27.
    • (2011) Nat Rev Drug Discov , vol.10 , pp. 417-427
    • Carmeliet, P.1    Jain, R.K.2
  • 7
    • 84856297005 scopus 로고    scopus 로고
    • Resistance to angiogenesis inhibitors in renal cell carcinoma
    • Tamaskar I, Dhillon J, Pili R. Resistance to angiogenesis inhibitors in renal cell carcinoma. Clin Adv Hematol Oncol 2011;9:101-10.
    • (2011) Clin Adv Hematol Oncol , vol.9 , pp. 101-110
    • Tamaskar, I.1    Dhillon, J.2    Pili, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.